DA
DCF Advisers Portfolio holdings
AUM
$208M
1-Year Return
21.52%
This Quarter Return
+3.74%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$191M
AUM Growth
+$25.5M
(+15%)
Cap. Flow
+$16.8M
Cap. Flow
% of AUM
8.76%
Top 10 Holdings %
Top 10 Hldgs %
46.39%
Holding
91
New
15
Increased
26
Reduced
10
Closed
3
Top Buys
| 1 |
Amazon
AMZN
|
$3.29M |
| 2 |
iShares Silver Trust
SLV
|
$2.57M |
| 3 |
Biohaven
BHVN
|
$1.79M |
| 4 |
Zoom
ZM
|
$1.78M |
| 5 |
Broadcom
AVGO
|
$1.57M |
Top Sells
| 1 |
Pan American Silver
PAAS
|
$679K |
| 2 |
Oracle
ORCL
|
$565K |
| 3 |
Amgen
AMGN
|
$562K |
| 4 |
Yeti Holdings
YETI
|
$482K |
| 5 |
Altimmune
ALT
|
$355K |
Sector Composition
| 1 | Healthcare | 34.09% |
| 2 | Technology | 24.79% |
| 3 | Communication Services | 9.83% |
| 4 | Consumer Discretionary | 6.02% |
| 5 | Financials | 3.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Nokia
NOK
$24.5B
| $189K | 0.1% |
50,000
| – | – |
|
77
Arq
ARQ
$311M
| $134K | 0.07% |
22,000
+6,000
| +38% | +$36.4K |
|
78
Lineage Cell Therapeutics
LCTX
$276M
| $107K | 0.06% |
107,751
| – | – |
|
|
TBHC
79
The Brand House Collective, Inc. Common Stock
TBHC
$33M
| $41.4K | 0.02% |
25,415
| – | – |
|
80
Ovid Therapeutics
OVID
$93.9M
| $32.1K | 0.02% |
41,750
+22,020
| +112% | +$16.9K |
|
81
Equillium
EQ
$64.7M
| $22.8K | 0.01% |
+32,962
| New | +$22.8K |
|
|
AMRN
82
Amarin Corp
AMRN
$307M
| – | – |
-665
| Closed | -$11.8K |
|
83
Esperion Therapeutics
ESPR
$488M
| – | – |
0
| – | – |
|
|
84
Pan American Silver
PAAS
$12.2B
| – | – |
-45,000
| Closed | -$679K |
|
85
Invesco QQQ Trust
QQQ
$365B
| – | – |
0
| – | – |
|
86
SPDR Portfolio S&P 500 ETF
SPLG
$83.6B
| – | – |
0
| – | – |
|
87
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – |
0
| – | – |
|
|
88
Yeti Holdings
YETI
$2.9B
| – | – |
-12,500
| Closed | -$482K |
|